Adjuvant Triple Therapy Boosts Survival in Biliary Cancers

Chemoradiation combined with immunotherapy significantly boosts survival in patients with resected extrahepatic cholangiocarcinoma and gallbladder cancer. Medscape Medical News

Read the full article on medscape.com